BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29956727)

  • 1. Polyphyllin I inhibits invasion and epithelial-mesenchymal transition via CIP2A/PP2A/ERK signaling in prostate cancer.
    Liu X; Sun Z; Deng J; Liu J; Ma K; Si Y; Zhang T; Feng T; Liu Y; Tan Y
    Int J Oncol; 2018 Sep; 53(3):1279-1288. PubMed ID: 29956727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyphyllin I Overcomes EMT-Associated Resistance to Erlotinib in Lung Cancer Cells via IL-6/STAT3 Pathway Inhibition.
    Lou W; Chen Y; Zhu KY; Deng H; Wu T; Wang J
    Biol Pharm Bull; 2017 Aug; 40(8):1306-1313. PubMed ID: 28515374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CIP2A cooperates with H-Ras to promote epithelial-mesenchymal transition in cervical-cancer progression.
    Wu Y; Gu TT; Zheng PS
    Cancer Lett; 2015 Jan; 356(2 Pt B):646-55. PubMed ID: 25458953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I.
    Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS
    J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paris polyphylla ethanol extract and polyphyllin I ameliorate adenomyosis by inhibiting epithelial-mesenchymal transition.
    Shi YX; Xu L; Wang X; Zhang KK; Zhang CY; Liu HY; Ding PP; Shi W; Liu ZY
    Phytomedicine; 2024 May; 127():155461. PubMed ID: 38452697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.
    Huang Q; Qin S; Yuan X; Zhang L; Ji J; Liu X; Ma W; Zhang Y; Liu P; Sun Z; Zhang J; Liu Y
    Oncol Rep; 2017 Jul; 38(1):598-606. PubMed ID: 28560452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Solanine inhibits invasion of human prostate cancer cell by suppressing epithelial-mesenchymal transition and MMPs expression.
    Shen KH; Liao AC; Hung JH; Lee WJ; Hu KC; Lin PT; Liao RF; Chen PS
    Molecules; 2014 Aug; 19(8):11896-914. PubMed ID: 25116803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of Polyphyllin I-induced apoptosis and reversal of the epithelial-mesenchymal transition in human osteosarcoma cells.
    Chang J; Wang H; Wang X; Zhao Y; Zhao D; Wang C; Li Y; Yang Z; Lu S; Zeng Q; Zimmerman J; Shi Q; Wang Y; Yang Y
    J Ethnopharmacol; 2015 Jul; 170():117-27. PubMed ID: 25978954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oridonin inhibits gefitinib-resistant lung cancer cells by suppressing EGFR/ERK/MMP-12 and CIP2A/Akt signaling pathways.
    Xiao X; He Z; Cao W; Cai F; Zhang L; Huang Q; Fan C; Duan C; Wang X; Wang J; Liu Y
    Int J Oncol; 2016 Jun; 48(6):2608-18. PubMed ID: 27082429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
    Qin G; Xu F; Qin T; Zheng Q; Shi D; Xia W; Tian Y; Tang Y; Wang J; Xiao X; Deng W; Wang S
    Oncotarget; 2015 Dec; 6(39):41794-808. PubMed ID: 26540629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.
    Li S; Lu J; Chen Y; Xiong N; Li L; Zhang J; Yang H; Wu C; Zeng H; Liu Y
    Cell Mol Immunol; 2017 Jul; 14(7):621-630. PubMed ID: 26996066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euxanthone suppresses tumor growth and metastasis in colorectal cancer via targeting CIP2A/PP2A pathway.
    Wang N; Zhou F; Guo J; Zhu H; Luo S; Cao J
    Life Sci; 2018 Sep; 209():498-506. PubMed ID: 30144452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
    Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
    Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
    Al-Azayzih A; Gao F; Somanath PR
    Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
    Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
    Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.
    Su B; Su J; Zeng Y; Liu F; Xia H; Ma YH; Zhou ZG; Zhang S; Yang BM; Wu YH; Zeng X; Ai XH; Ling H; Jiang H; Su Q
    Oncotarget; 2016 Mar; 7(9):10498-512. PubMed ID: 26871290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A.
    Yu HC; Hung MH; Chen YL; Chu PY; Wang CY; Chao TT; Liu CY; Shiau CW; Chen KF
    Cell Death Dis; 2014 Jul; 5(7):e1359. PubMed ID: 25077545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cucurbitacin B reverses multidrug resistance by targeting CIP2A to reactivate protein phosphatase 2A in MCF-7/adriamycin cells.
    Cai F; Zhang L; Xiao X; Duan C; Huang Q; Fan C; Li J; Liu X; Li S; Liu Y
    Oncol Rep; 2016 Aug; 36(2):1180-6. PubMed ID: 27350399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.